| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Diabetes and cancer: a consensus report.
|
Diabetes Care
|
2010
|
6.71
|
|
2
|
Diabetes and cancer: a consensus report.
|
CA Cancer J Clin
|
2010
|
3.95
|
|
3
|
Adiponectin is a negative regulator of bone mineral and bone strength in growing mice.
|
Exp Biol Med (Maywood)
|
2008
|
1.76
|
|
4
|
Elevated circulating adiponectin and elevated insulin sensitivity in adiponectin transgenic mice are not associated with reduced susceptibility to colon carcinogenesis.
|
Int J Cancer
|
2009
|
1.50
|
|
5
|
Statins and cancer development.
|
Cancer Epidemiol Biomarkers Prev
|
2005
|
1.29
|
|
6
|
The case for strategic international alliances to harness nutritional genomics for public and personal health.
|
Br J Nutr
|
2005
|
1.24
|
|
7
|
Sp1 coordinately regulates de novo lipogenesis and proliferation in cancer cells.
|
Int J Cancer
|
2010
|
1.13
|
|
8
|
Bone abnormalities in adolescent leptin-deficient mice.
|
Regul Pept
|
2006
|
1.13
|
|
9
|
Effects of dietary folate on the development and progression of mammary tumors in rats.
|
Carcinogenesis
|
2005
|
1.05
|
|
10
|
Mevalonate promotes the growth of tumors derived from human cancer cells in vivo and stimulates proliferation in vitro with enhanced cyclin-dependent kinase-2 activity.
|
J Biol Chem
|
2004
|
1.05
|
|
11
|
Polygenic control of hepatocarcinogenesis in Copenhagen x F344 rats.
|
Int J Cancer
|
2004
|
1.05
|
|
12
|
Fatty acid synthase is a potential molecular target for the chemoprevention of breast cancer.
|
Carcinogenesis
|
2004
|
0.96
|
|
13
|
Regulation of HMG-CoA reductase in MCF-7 cells by genistein, EPA, and DHA, alone and in combination with mevastatin.
|
Cancer Lett
|
2004
|
0.95
|
|
14
|
Geraniol and beta-ionone inhibit proliferation, cell cycle progression, and cyclin-dependent kinase 2 activity in MCF-7 breast cancer cells independent of effects on HMG-CoA reductase activity.
|
Biochem Pharmacol
|
2004
|
0.93
|
|
15
|
Farnesol decreases serum triglycerides in rats: identification of mechanisms including up-regulation of PPARalpha and down-regulation of fatty acid synthase in hepatocytes.
|
Lipids
|
2008
|
0.90
|
|
16
|
Insulin-like growth factor binding protein-1 over-expression in transgenic mice inhibits hepatic preneoplasia.
|
Mol Carcinog
|
2003
|
0.89
|
|
17
|
Dietary factors and the regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase: implications for breast cancer and development.
|
Mol Nutr Food Res
|
2005
|
0.87
|
|
18
|
Cyclin D1 is necessary but not sufficient for anchorage-independent growth of rat mammary tumor cells and is associated with resistance of the Copenhagen rat to mammary carcinogenesis.
|
Oncogene
|
2003
|
0.86
|
|
19
|
Development of aberrant crypt foci in the colons of ob/ob and db/db mice: evidence that leptin is not a promoter.
|
Mol Carcinog
|
2008
|
0.84
|
|
20
|
Colon carcinogenesis in liver-specific IGF-I-deficient (LID) mice.
|
Int J Cancer
|
2008
|
0.83
|
|
21
|
mda-7/IL-24 expression inhibits breast cancer through upregulation of growth arrest-specific gene 3 (gas3) and disruption of β1 integrin function.
|
Mol Cancer Res
|
2013
|
0.83
|
|
22
|
Cyclooxygenase-2 overexpression in MCF-10F human breast epithelial cells inhibits proliferation, apoptosis and differentiation, and causes partial transformation.
|
Int J Cancer
|
2005
|
0.82
|
|
23
|
Cyclooxygenase-2 inhibitor celecoxib inhibits promotion of mammary tumorigenesis in rats fed a high fat diet rich in n-6 polyunsaturated fatty acids.
|
Cancer Lett
|
2002
|
0.81
|
|
24
|
Celecoxib decreases fatty acid synthase expression via down-regulation of c-Jun N-terminal kinase-1.
|
Exp Biol Med (Maywood)
|
2007
|
0.81
|
|
25
|
Statins and the risk of cancer.
|
JAMA
|
2006
|
0.81
|
|
26
|
Effects of dietary conjugated linoleic acid on the expression of uncoupling proteins in mice and rats.
|
Lipids
|
2002
|
0.80
|
|
27
|
Inhibition of fatty acid synthase and Sp1 expression by 3,3'-diindolylmethane in human breast cancer cells.
|
Nutr Cancer
|
2011
|
0.80
|
|
28
|
The 10t,12c isomer of conjugated linoleic acid inhibits fatty acid synthase expression and enzyme activity in human breast, colon, and prostate cancer cells.
|
Nutr Cancer
|
2010
|
0.79
|
|
29
|
Statins and cancer.
|
Epidemiology
|
2007
|
0.79
|
|
30
|
Fatty acid synthase is over-expressed in large aberrant crypt foci in rats treated with azoxymethane.
|
Int J Cancer
|
2009
|
0.77
|
|
31
|
Farnesol induces thyroid hormone receptor (THR) beta1 but inhibits THR-mediated signaling in MCF-7 human breast cancer cells.
|
Biochem Biophys Res Commun
|
2006
|
0.76
|
|
32
|
Tissue-specific resistance to cancer development in the rat: phenotypes of tumor-modifier genes.
|
Carcinogenesis
|
2002
|
0.76
|
|
33
|
Interleukin-24 induces expression of beta4 integrin but suppresses anchorage-independent growth of rat mammary tumor cells by a mechanism that is independent of beta4.
|
Mol Cancer Res
|
2009
|
0.76
|
|
34
|
The effect of physiological concentrations of sex hormones, insulin, and glucagon on growth of breast and prostate cells supplemented with unmodified human serum.
|
In Vitro Cell Dev Biol Anim
|
2010
|
0.76
|
|
35
|
Dehydroalanine and lysinoalanine in thermolyzed casein do not promote colon cancer in the rat.
|
Food Chem Toxicol
|
2008
|
0.75
|
|
36
|
Creatine: a safety concern.
|
Toxicol Lett
|
2004
|
0.75
|
|
37
|
The use of creatine to enhance athletic performance.
|
Nutrition
|
2004
|
0.75
|
|
38
|
Delivery of mevalonate to murine extrahepatic tissues via mini-osmotic pumps.
|
J Pharmacol Toxicol Methods
|
2004
|
0.75
|
|
39
|
Reduced susceptibility of muscle-specific insulin receptor knockout mice to colon carcinogenesis.
|
Am J Physiol Gastrointest Liver Physiol
|
2008
|
0.75
|
|
40
|
Ezetimibe reverses the inhibitory effects of dietary cholesterol on mammary tumorigenesis in rats.
|
Int J Cancer
|
2010
|
0.75
|